Cargando…
Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456545/ https://www.ncbi.nlm.nih.gov/pubmed/32354772 http://dx.doi.org/10.1136/annrheumdis-2020-217362 |
_version_ | 1783575817938272256 |
---|---|
author | Duret, Pierre-Marie Sebbag, Eden Mallick, Auriane Gravier, Simon Spielmann, Lionel Messer, Laurent |
author_facet | Duret, Pierre-Marie Sebbag, Eden Mallick, Auriane Gravier, Simon Spielmann, Lionel Messer, Laurent |
author_sort | Duret, Pierre-Marie |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7456545 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-74565452020-09-04 Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept Duret, Pierre-Marie Sebbag, Eden Mallick, Auriane Gravier, Simon Spielmann, Lionel Messer, Laurent Ann Rheum Dis Letter BMJ Publishing Group 2020-09 2020-04-30 /pmc/articles/PMC7456545/ /pubmed/32354772 http://dx.doi.org/10.1136/annrheumdis-2020-217362 Text en © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage |
spellingShingle | Letter Duret, Pierre-Marie Sebbag, Eden Mallick, Auriane Gravier, Simon Spielmann, Lionel Messer, Laurent Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept |
title | Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept |
title_full | Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept |
title_fullStr | Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept |
title_full_unstemmed | Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept |
title_short | Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept |
title_sort | recovery from covid-19 in a patient with spondyloarthritis treated with tnf-alpha inhibitor etanercept |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456545/ https://www.ncbi.nlm.nih.gov/pubmed/32354772 http://dx.doi.org/10.1136/annrheumdis-2020-217362 |
work_keys_str_mv | AT duretpierremarie recoveryfromcovid19inapatientwithspondyloarthritistreatedwithtnfalphainhibitoretanercept AT sebbageden recoveryfromcovid19inapatientwithspondyloarthritistreatedwithtnfalphainhibitoretanercept AT mallickauriane recoveryfromcovid19inapatientwithspondyloarthritistreatedwithtnfalphainhibitoretanercept AT graviersimon recoveryfromcovid19inapatientwithspondyloarthritistreatedwithtnfalphainhibitoretanercept AT spielmannlionel recoveryfromcovid19inapatientwithspondyloarthritistreatedwithtnfalphainhibitoretanercept AT messerlaurent recoveryfromcovid19inapatientwithspondyloarthritistreatedwithtnfalphainhibitoretanercept |